期刊文献+

NQO1基因多态性与大肠癌遗传易感性 被引量:11

The NAD(P)H: Quinone Oxidoreductase 1 Gene Polymorphism and its Association with Colorectal Cancer
暂未订购
导出
摘要 目的:探讨依赖还原型辅酶Ⅰ/Ⅱ:醌氧化还原酶(NQO1)基因多态性与大肠癌遗传易感性之间的相关性。方法:采用聚合酶链反应—限制性片段长度多态性(PCR-RFLP)基因型分析技术对101例大肠癌患者及103例对照者NQO1cDNA609位点多态性进行测定。结果:基因型频率分布在大肠癌组与对照组差异显著(χ2=9.52,P<0.01),T/T基因型携带者大肠癌患病危险性是野生纯合型(C/C)的3.56倍(OR=3.56,95%CI为1.58~7.96)。NQO1T等位基因及C等位基因频率在大肠癌组与对照组分别为42.1%、57.3%,57.9%、42.7%,T等位基因频率两组有显著差异(χ2=9.43,P<0.01),T等位基因携带者患大肠癌的危险性是C等位基因携带者的1.85倍,(OR=1.85,95%CI为1.25~2.73)。结论:NQO1在大肠癌的形成过程中起一定的保护作用,而NQO1cDNA609位点T等位基因可能是大肠癌发生的危险因素,NQO1基因的多态性与生活特征共同决定个体大肠癌的患病风险。 Objective: To investigate the association between colorectal cancer genetic susceptibility and the genetic polymorphism of NQO1 NAD(P)H: quinone oxidoreductase 1 gene caused by the point mutation of cDNA 609 C to T. Methods: The polymorphism of NQO1 gene was analyzed in 101 colorectal cancer patients and 103 adult individuals by utilizing PCR-RFLP (polymerase chain reaction restriction fragment length polymorphism ) genotyping assay technique. Results: There is a significance difference in the frequencies of the mutated NQO1 genotype (T/T): 0.327 for cancer patients and 0.175 for control individuals (χ2=9.52, P<0.01). The individuals with the T/T genotype had a increasing cancer risk than individuals with C/C genotypes; the OR for T/T versus C/C was 3.56 (95% CI, 1.58-7.96). The frequency distribution of T allele and C allele was 42.1% and 57.3% in cases and 57.9% and 42.7% in controls, respectively (χ2=9.42, P<0.01). The individuals with the T allele had a slight increasing cancer risk than individuals with C allele; the OR for T versus C was 1.85 (95% CI, 1.25-2.73). Conclusion: This study may suggest a protect role of the NQO1 wild type(C/C) in the colorectal tumorgenesis and the cDNA 609T allele of NQO1gene may be the risk factor of colorectal cancer. There is also that the individual's overall susceptibility to colorectal cancer is a consequence of both an inheritable trait in NQO1 metabolism and a behavioral trait in individual living characteristics.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第2期89-91,共3页 Chinese Journal of Clinical Oncology
关键词 依赖还原型辅酶Ⅰ/Ⅱ 醌氧化还原酶 大肠癌遗传易感性 基因 态性 NQo1NAD(P)H: quinone oxidoreductase 1 Colorectal cancer Susceptibility to cancer Genetic polymorphism
  • 相关文献

参考文献11

  • 1[1]Jaiswal AK, McBride OW, Adesnik M, et al. Human dioxininducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16[J]. J Biol Chem, 1988, 263(27): 13572~13578
  • 2[2]Tvaver RD, Horikosh T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity [J]. Cancer Res, 1992, 52(4): 797~802
  • 3[3]Monks TJ, Hanzlik RP, Cohen GM, et al. Quinone chemistry and toxicity[J]. Toxicol Appl Pharmacol, 1992, 112(1): 2~16
  • 4[4]Siegel D, Anwar A, Winski SL, et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD (P)H:quinone oxidoreductase 1 [J]. Mol Pharmacol, 2001, 59(2):263 ~268
  • 5[5]Kuehl BL, Paterson JW, Peacock JW, et al. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity[J]. Br J Cancer, 1995, 72(3): 555~561
  • 6[6]Kelsey KT, Ross D, Traver RD, et al. Ethnic variation in the prevalence of a common NAD (P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy[J]. BrJ Cancer, 1997, 76(7): 852~854
  • 7[7]Gaedigk A, Tyndale RF, Jurima-Romet M, et al. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations[J]. Pharmacogenetics, 1998, 8(4): 305~313
  • 8[8]Long DJ 2nd, Waikel RL, Wang XJ, et al. NAD (P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to,12-dimethyl-benz [a]-anthracene induced carcinogenesis in mouse skin[J]. J Natl Cancer Inst, 2001, 93(15): 1166~1170
  • 9[9]Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1[J]. Proc Natl Acad Sci USA, 2001, 98(3): 1188~1193
  • 10[10]Asher G, Lotem J, Kama R, et al. NQO1 stabilizes p53through a distinct pathway[J]. Natl Acad Sci USA, 2002, 99(5): 3099~3104

同被引文献107

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部